Clinical Trials Directory

Trials / Completed

CompletedNCT03728192

In-vitro Effect of Mangosteen Pericarp Extract on Cell Lines

Inhibition and Cytotoxic Effects of Mangosteen on Cell Lines

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Meenakshi Ammal Dental College and Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The present study is an effort to investigate the hypothesis that in-vitro vitality and antiapoptotic effect of alcoholic crude extract of mangosteen on Oral cancer( H357) cell lines and Cevical cancer (HeLa) cell lines.

Detailed description

The oral and cervical cells were investigated by MTT (3-4,5- dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, DNA fragmentation detection by TUNEL (Terminal deoxynucleotidyl transferase-mediated d-UTP Nick End Labeling) assay and Apototic assay using Annexin V/FITC Kit.

Conditions

Interventions

TypeNameDescription
OTHERmangosteen extractFor Mangosteen group :DNA fragmentation assay is used to identify apoptosis.1×106 cells were harvested and treated with mangosteen pericarp extract for 48 h For Camptothecin group : Cells were also treated with standard anticancer drug Camptothecin to act as a positive control.

Timeline

Start date
2016-03-07
Primary completion
2016-05-11
Completion
2018-07-13
First posted
2018-11-02
Last updated
2018-11-02

Source: ClinicalTrials.gov record NCT03728192. Inclusion in this directory is not an endorsement.